SYUP.US ANBC INC
- Market cap
- USD 23.9K
- P/E
- -
- P/B
- -
- ROE
- 69.7%
- Dividend yield
- 2,852.89%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2017.
Is SYUP.US undervalued?
Graham numberThe Graham number of ANBC INC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ANBC INC fundamental analysis
No fundamental analysis for ANBC INC yet.
ANBC INC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ANBC INC
ANBC, INC. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution …
Full company profileANBC INC financial statements
ANBC INC annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2004 | 2005 | 2006 | 2007 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 858K | 541K | 312K | 50.9K | 2.16M | 2.87M | 3.16M |
| Gross Profit | 588K | 460K | 110K | -184K | 1.12M | 1.37M | 1.55M |
| Operating Income | -800K | -2.47M | -324K | -184K | 813K | 1.24M | 1.35M |
| EBITDA | - | - | - | -26.3K | - | 1.36M | 1.45M |
| Net Income | -799K | -2.47M | -324K | -382K | 784K | 1.21M | 1.30M |
| EPS | - | - | - | -0.02 | - | 0.06 | 0.02 |
| Balance Sheet | |||||||
| Total Assets | 5.74M | 4.88M | 6.25M | 6.28M | 974K | 1.66M | 2.67M |
| Total Liabilities | 3.54M | 3.23M | 4.52M | 4.81M | 993K | 501K | 809K |
| Shareholders' Equity | 2.20M | 1.65M | 1.73M | 1.47M | -18.6K | 1.16M | 1.86M |
| Cash & Short-term Investments | 262K | 54.0K | 114K | 10.3K | 37.7K | 11.1K | 78.9K |
| Total Debt | - | - | - | 3.77M | - | - | - |
| Cash Flow | |||||||
| Operating Cash Flow | 1.15M | -52.7K | -418K | 78.5K | 54.7K | -6.25K | 795K |
| Capital Expenditure | 2.18M | 762K | 762K | 415K | 33.4K | 48.9K | 48.9K |
| Free Cash Flow | - | - | - | -337K | - | -6.25K | 746K |
| Ratios | |||||||
| ROE | -36.2% | -149.4% | -18.7% | -26.0% | - | 104.8% | 69.7% |
| ROA | -13.9% | -50.6% | -5.2% | -6.1% | 80.4% | 73.1% | 48.6% |
| Net Profit Margin | -93.1% | -456.2% | -103.5% | -750.3% | 36.3% | 42.2% | 41.1% |
| Debt to Equity | - | - | - | 2.57x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
ANBC INC dividends
- Dividend yield
- 2,852.89%
- Forward dividend
- -
- Payout ratio
- 52.5%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2017 | USD 681K | 0.01 | 52.5% |
| 2016 | USD 681K | 0.03 | 56.2% |
| 2015 | USD 681K | - | 86.9% |
| 2007 | - | - | - |
| 2006 | - | - | - |
| 2005 | - | - | - |
| 2004 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 5:1 on Jul 15, 2005.
Who owns ANBC INC
Ownership data of ANBC INC is not available yet.
ANBC INC company profile
- Company name
- ANBC INC
- Ticker
- SYUP.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- No 2020 Huqingping Road, Shanghai, China, 201702
- Phone
- 86 21 5976 0042
- Website
- -
About ANBC INC
ANBC, INC. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion. It also offers Ban-lan-gen that relieves cold and flu symptoms; Gan-mao-qing-re that relieves minor body aches and pains, and reduces fever; Huang-dan-yin-chen used in the treatment for jaundice infection hepatitis; and Liu-shen-qu for treatment of vomitings and dysentery. It offers its products to distributors on a wholesale basis. ANBC, INC. was formerly known as Shanghai Yutong Pharma, Inc. and changed its name to ANBC, INC. in August 2016. The company was incorporated in 2003 and is based in Shanghai, China.
ANBC INC management
3- Mr. Wei DongChief Executive Officer · born 1957
- Mr. Lu Jiang'anPresident, Principal Financial Officer and Principal Accounting Officer · born 1956
- Ms. Lee LishiaSecretary and Treasurer · born 1949